Back to XTX Topco Ltd XTX Topco Ltd

ARQTARQT

Showing 8 of 14 quarters

Position history for XTX Topco LtdXTX Topco Ltd's holdings in Arcutis Biotherapeutics, Inc.

Yes. XTX Topco holds 45,545 shares of ARQT (Arcutis Biotherapeutics), worth $1.2M, as of its Q2 2026 13F filing. It increased the position by 2,861 shares (+6.7%) from Q1 2026. XTX Topco has held ARQT since Q1 2025, across 6 quarterly 13F filings.

Current Value

$1.2M

Current Shares

45,545

Total Value Change

+$750,320

Total Shares Change

-2,183

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
45,545
+6.7%
$1.2M0.0%$26.22
27
2026-Q1
Decreased
42,684
-42.6%
$1M0.0%$23.56
0
2025-Q4
Increased
74,358
+557.9%
$2.2M0.1%$29.04
42
2025-Q3
Decreased
11,303
-69.9%
$213,0620.0%$18.85
0
2025-Q2
Decreased
37,555
-49.0%
$526,5210.0%$14.02
0
2025-Q1
New
73,676
—
$1.2M0.1%$15.64
35
2024-Q4
Exited
0
-100.0%
$00.0%$13.93
0
2024-Q3
Increased
47,728
+30.9%
$443,8700.0%$9.30
30

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used